# Amgen USA Inc.

Canonical: https://abierto.us/vendors/amgen-usa-inc-xpgnqmxhp493

- UEI: XPGNQMXHP493
- CAGE: 5YNZ4
- Location: Thousand Oaks, CA
- Awards in window: 4 (24 transactions), $125,985,021 obligated, January 5, 2026 to August 19, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $125,985,021
- Department of Veterans Affairs: 3 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $125,985,021
- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 4 awards

## Largest awards

- 75A50122C00065 (definitive contract): $125,985,021, Barda - Aspr / Daappo / Barda DCMA. Exercise Option Period 4 and Modify the Number of Doses. Change the Period of Performance to March 4, 2026 Through September 29, 2032. the Total Contract Funded Value Increased from $713,890,168.42 by $59,988,838.10 to $773,879,006.52.. https://www.usaspending.gov/award/CONT_AWD_75A50122C00065_7505_-NONE-_-NONE-/
- 36E79725D0009: $0, Nac Pharmaceuticals. 2026 Subcontracting Plan. https://www.usaspending.gov/award/CONT_IDV_36E79725D0009_3600/
- 36E79725D0053: $0, Nac Pharmaceuticals. Incorporate 2026 Amgen Subcontracting Plan.. https://www.usaspending.gov/award/CONT_IDV_36E79725D0053_3600/
- 36F79721D0086: $0, Nac Federal Supply Schedule. NDC Change. https://www.usaspending.gov/award/CONT_IDV_36F79721D0086_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/amgen-usa-inc-xpgnqmxhp493.